Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

PlexusDx vs TeleHealth Weight Solutions

PlexusDx
Graded #158

Higher grade

vs+6.600000000000001
TeleHealth Weight Solutions
Graded #302

Lower grade

The verdict

PlexusDx takes it — 67.7/100 to 61.1/100.

PlexusDx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. PlexusDx (plexusdx.com) is a US GLP-1 telehealth platform offering compounded weight-loss medications with licensed providers in all 50 states.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valuePlexusDx +29
74
45
Dose & formulationTeleHealth Weight Solutions +8
64
72
Clinical oversightTeleHealth Weight Solutions +2
74
76
Labs & monitoringEven
52
52
FulfillmentPlexusDx +11
78
67
Contract termsEven
55
55
PlexusDx · left barTeleHealth Weight Solutions · right bar

The numbers

MetricPlexusDxTeleHealth Weight Solutions
WeighScore67.7/10061.1/100
GradeCC
Scorecard rank#158#302
Semaglutide$149/mo (starting dose, compounded)$325/mo (all doses, compounded)
Tirzepatide$249/mo (starting dose, compounded)$375/mo
CoverageAll 50 statesCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
PlexusDx

Graded #158 · C

Strengths

  • Licensed providers available in all 50 states
  • Range of options including low-cost microdose GLP-1 from $129/mo
  • Optional Precision Peptide genetic panel adds a personalization angle
  • Independent clinician review via state-licensed telehealth platform
  • Compounded medications from state-licensed pharmacies

Where it loses points

  • Compounded medications only; no FDA-approved brand options
  • Specific compounding pharmacies not named
  • Genetic-panel upsell may not add clinical value for everyone
  • Tirzepatide pricing from $249/mo is higher than budget rivals
  • No insurance accepted

Strengths

  • Both compounded semaglutide and tirzepatide offered with published pricing
  • Low refill pricing (from about 60 dollars per month) after the initial supply
  • Broad advertised reach across 43 states with home delivery of medication and supplies

Where it loses points

  • Dispensing pharmacy is not publicly named
  • Specific states served are not listed and the site also shows a separate Medi Health Clinics brand
  • 125-dollar transfer fee for outside prescriptions

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard